menu
    • menu

    Company profile for Enzolytics

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Enzolytics, Inc. is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Enzolytics is committed to creating drugs for the better health of mankind. Enzolytics, Inc.'s flagship compound ITV-1 is a suspension of Inactivated Pepsin Fragment (IPF), which studies have shown is effective in the treatment of HIV. IPF is the active drug subs...
    Enzolytics, Inc. is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Enzolytics is committed to creating drugs for the better health of mankind. Enzolytics, Inc.'s flagship compound ITV-1 is a suspension of Inactivated Pepsin Fragment (IPF), which studies have shown is effective in the treatment of HIV. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system. IPF is a platform technology that can be used to facilitate a broad range of applications.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    EnzolyticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    P.O. Box 5756 Frisco, TX
    Telephone
    Telephone
    (972)-292-9414
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://enzolytics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bulgarian Academy Reports On IPF As Immunomodulator
    Bulgarian Academy Reports On IPF As Immunomodulator

    18 Sep 2024

    // ACCESSWIRE

    https://www.accesswire.com/919663/bulgarian-academy-of-sciences-issues-report-on-results-of-its-in-vivo-testing-of-ipf-as-an-immunomodulator

    ACCESSWIRE
    18 Sep 2024
    Share Share
    Department Of Immunology And Enzolytics Execute Three-Year Deal
    Department Of Immunology And Enzolytics Execute Three-Year Deal

    09 Sep 2024

    // ACCESSWIRE

    https://www.accesswire.com/914775/department-of-immunology-institute-of-microbiology-bulgarian-academy-of-sciences-and-enzolytics-inc-execute-three-year-agreement

    ACCESSWIRE
    09 Sep 2024
    Share Share
    Enzolytics And Bulgarian Academy Partner On Immunology Research
    Enzolytics And Bulgarian Academy Partner On Immunology Research

    31 Jul 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=894883&lang=en

    ACCESSWIRE
    31 Jul 2024
    Share Share
    Enzolytics Enters Exclusive License For Patented Immunotherapy Cancer Treatment
    Enzolytics Enters Exclusive License For Patented Immunotherapy Cancer Treatment

    01 Jul 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=883855&lang=en

    ACCESSWIRE
    01 Jul 2024
    Share Share
    Enzolytics To Invest In Room Temperature SPAD With Sagaliam
    Enzolytics To Invest In Room Temperature SPAD With Sagaliam

    03 Jun 2024

    // ACCESSWIRE

    https://www.accesswire.com/870749/enzolytics-inc-poised-to-invest-alongside-sagaliam-acquisition-corp-in-revolutionary-room-temperature-spad-technology

    ACCESSWIRE
    03 Jun 2024
    Share Share
    Enzolytics Announces Nitric Oxide Formulation Licensing Intent
    Enzolytics Announces Nitric Oxide Formulation Licensing Intent

    22 May 2024

    // ACCESSWIRE

    https://www.accesswire.com/866307/enzolytics-inc-announces-letter-of-intent-for-exclusive-licensing-agreement-for-patented-nitric-oxide-formulation

    ACCESSWIRE
    22 May 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search